OXIS 8-K 02-02-2010

Company

GT Biopharma, Inc.

Filed

February 16, 2010

Period of Report

February 10, 2010

Accession Number

0000109657-10-000005

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →